Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1

Autor:	Miki Suzuki, Takayoshi Suzuki, Daisuke Ogasawara, Hiroki Tsumoto, Yukihiro Itoh, Yosuke Ota, Mohammed Naseer Ahmed Khan, Naoki Miyata, Tamio Mizukami, Hidehiko Nakagawa
Rok vydání:	2015
Předmět:	Pharmacology Histone H3 Lysine 4 Cell growth Organic Chemistry Pharmaceutical Science Biological activity Biology biology.organism_classification Biochemistry Molecular biology HeLa Histone Cell culture Drug Discovery biology.protein Molecular Medicine Demethylase Demethylation
Zdroj:	MedChemComm. 6:407-412
ISSN:	2040-2511 2040-2503
DOI:	10.1039/c4md00330f
Popis:	Lysine-specific demethylase 1 (LSD1), the first histone demethylase to be identified, catalyzes specifically the demethylation of the mono- and dimethyl groups of histone H3 lysine 4, and its dysregulation is thought to contribute to the development of cancer. We have recently reported that NCL1 (4) is the first cell-active LSD1-selective inhibitor. To find LSD1 inhibitors that show higher potency than NCL1 (4), we designed and synthesized an N-alkylated analogue of NCL1 (5), and evaluated its biological activity. In enzyme assays, compound 5 was six times more potent than 4, and compound 5 exhibited cell growth inhibition in cervical cancer HeLa cell line and neuroblastoma SH-SY5Y cell line. Compound 5 should be useful as a lead structure for anticancer drugs.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::12a19ae265d644807d3e0c01d9b2ebbf https://doi.org/10.1039/c4md00330f Zobrazit plný text záznamu